FDA Approves Rytary, Extended-Release Oral Treatment for PD

Share

(January 9, 2015) - The US Food and Drug Administration has approved Rytary (carbidopa/levodopa), extended-release capsules for the treatment of Parkinson's disease. Rytary is expected to launch in February, 2015. Read more…

Click for a printer friendly version

Back to top